Filing Details
- Accession Number:
- 0001235802-17-000013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-10 16:50:47
- Reporting Period:
- 2017-01-09
- Filing Date:
- 2017-01-10
- Accepted Time:
- 2017-01-10 16:50:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1374128 | Entellus Medical Inc | ENTL | Surgical & Medical Instruments & Apparatus (3841) | 204627978 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1625112 | E Karen Peterson | 3600 Holly Lane North, Suite 40 Plymouth MN 55447 | Vp, Regulatory And Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Disposition | 2017-01-09 | 5,000 | $19.12 | 48,224 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2017-01-10 | 4,840 | $19.10 | 43,384 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.10 to $19.12, inclusive. The Reporting Person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form.
- Includes 10,000 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.10 to $19.11, inclusive. The Reporting Person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form.
Billionaire Hedge Funds
